Cardiovascular Systems Inc Revenue Growth Rates (CSII), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cardiovascular Systems Inc   (NASDAQ: CSII)
 

CSII's Revenue Growth by Quarter and Year

Cardiovascular Systems Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CSII Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter June -
3rd Quarter March -
2nd Quarter December 61.45
1st Quarter September 59.67
FY 121.12

CSIIs Annual Revenue
Cardiovascular Systems Inc 's Revenue in the fiscal year 2022 $ 236.22 millions
Cardiovascular Systems Inc 's Revenue in the fiscal year 2021 $ 258.97 millions
Cardiovascular Systems Inc 's Revenue in the fiscal year 2020 $ 236.55 millions
Cardiovascular Systems Inc 's Revenue in the fiscal year 2019 $ 248.02 millions
Cardiovascular Systems Inc 's Revenue in the fiscal year 2018 $ 217.04 millions




CSII Revenue second quarter 2023 Y/Y Growth Comment
Cardiovascular Systems Inc reported Revenue growth of 3.91% year on year in the second quarter 2023, to $ 61.45 millions, this is lower than Cardiovascular Systems Inc 's recent average Revenue growth of 10%.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 117 other companies have achieved higher Revenue growth. While Cardiovascular Systems Inc ' s Revenue increase of 3.91% ranks overall at the positon no. 2675 in the second quarter 2023.


CSII Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter June - -11.96 % 66.84 % -37.64 %
3rd Quarter March - -11.14 % 3.42 % -3.36 %
2nd Quarter December 3.91 % -7.84 % -6.09 % 13.49 %
1st Quarter September 2.23 % -3.58 % -6.12 % 14.61 %
FY   - -8.78 % 9.48 % -

Financial Statements
Cardiovascular Systems Inc 's second quarter 2023 Revenue $ 61.45 millions CSII's Income Statement
Cardiovascular Systems Inc 's second quarter 2022 Revenue $ 59.14 millions Quarterly CSII's Income Statement


CSII Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter June - 11.17 % 12.2 % -30.45 %
3rd Quarter March - -4.94 % -1.4 % -10.46 %
2nd Quarter December 2.99 % 1.32 % 6 % 5.95 %
1st Quarter September -4.53 % -17.78 % 42.28 % -5.48 %
FY (Year on Year)   - -8.78 % 9.48 % -


Back to CSII Growth rate Comparisons >> Back to CSII Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #383
Overall #2675

Revenue Y/Y Growth Statistics
High Average Low
66.85 % 10 % -37.65 %
(Jun 30 2021)   (Jun 30 2020)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #118
Healthcare Sector #383
Overall #2675
Revenue Y/Y Growth Statistics
High Average Low
66.85 % 10 % -37.65 %
(Jun 30 2021)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Cardiovascular Systems Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
96.85 % -0.3 % -100 %
(Jun 30 2013)  


CSII's II. Quarter Q/Q Revenue Comment
Cardiovascular Systems Inc achieved in the II. Quarter 2023 above company average sequential Revenue growth of 2.99%, to $ 61.45 millions, from $59.67 millions in the first quarter.
CSII is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 137 other companies have achieved higher Revenue quarter on quarter growth. While Cardiovascular Systems Inc 's Revenue growth quarter on quarter, overall rank is 2091.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #431
Overall #2091
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #431
Overall #2091
Revenue Q/Q Growth Statistics
High Average Low
96.85 % -0.3 % -100 %
(Jun 30 2013)  


CSII's II. Quarter Q/Q Revenue Comment
Cardiovascular Systems Inc achieved in the II. Quarter 2023 above company average sequential Revenue growth of 2.99%, to $ 61.45 millions, from $59.67 millions in the first quarter.
CSII is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 137 other companies have achieved higher Revenue quarter on quarter growth. While Cardiovascular Systems Inc 's Revenue growth quarter on quarter, overall rank is 2091.


Cardiovascular Systems Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 239.84 $ 237.53 $ 236.22 $ 244.71 $ 251.77
Y / Y Revenue Growth (TTM) -4.74 % -7.51 % -8.79 % 6.15 % 10.21 %
Year on Year Revenue Growth Overall Ranking # 2157 # 1528 # 2742 # 2566 # 156
Seqeuential Revenue Change (TTM) 0.98 % 0.55 % -3.47 % -2.8 % -1.96 %
Seq. Revenue Growth (TTM) Overall Ranking # 3095 # 1268 # 3026 # 1773 # 920


Cumulative Revenue growth Comment
Cardiovascular Systems Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2022. If the fiscal year would end in Dec 31 2022, Cardiovascular Systems Inc 's annual Revenue decline would be -4.74% year on year to $240 millions.

In the Healthcare sector 280 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1528 to 2157.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 281
Overall # 2157

Revenue TTM Y/Y Growth Statistics
High Average Low
32.89 %
 7.01 %
-13.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 120
Sector # 421
S&P 500 # 3095
Cumulative Revenue growth Comment
Cardiovascular Systems Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2022. If the fiscal year would end in Dec 31 2022, Cardiovascular Systems Inc 's annual Revenue fall would be -4.74% year on year to $240 millions.

In the Healthcare sector 280 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1528 to 2157.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 281
Overall # 2157

Revenue TTM Y/Y Growth Statistics
High Average Low
32.89 %
7.01 %
-13.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 120
Sector # 421
S&P 500 # 3095




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CSII's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Intuitive Surgical Inc 6.73%$ 6.726 millions
Scienture Holdings Inc 6.55%$ 6.549 millions
Atrion Corporation6.36%$ 6.358 millions
Armata Pharmaceuticals Inc 6.27%$ 6.269 millions
Genedx Holdings Corp 6.14%$ 6.140 millions
Medicure Inc 6.08%$ 6.075 millions
Kymera Therapeutics Inc 5.66%$ 5.656 millions
Intellia Therapeutics Inc 5.59%$ 5.594 millions
Merit Medical Systems Inc5.36%$ 5.359 millions
Universal Health Services Inc 5.24%$ 5.243 millions
Supernus Pharmaceuticals inc 5.20%$ 5.205 millions
Alcon inc 5.14%$ 5.138 millions
Phibro Animal Health Corporation5.13%$ 5.128 millions
Utah Medical Products Inc5.12%$ 5.118 millions
Tandem Diabetes Care Inc 5.00%$ 5.002 millions
Butterfly Network Inc 4.99%$ 4.993 millions
Perrigo Company Plc4.55%$ 4.552 millions
Acadia Pharmaceuticals Inc 4.38%$ 4.384 millions
Sotera Health Company4.29%$ 4.286 millions
Corcept Therapeutics Inc4.28%$ 4.284 millions
Galapagos Nv4.21%$ 4.215 millions
Icon Plc4.08%$ 4.078 millions
Caredx Inc 3.99%$ 3.994 millions
Cardiovascular Systems Inc 3.92%$ 3.920 millions
Koninklijke Philips Nv3.91%$ 3.911 millions
Ati Physical Therapy Inc 3.85%$ 3.853 millions
Valneva Se3.80%$ 3.797 millions
Aesthetic Medical International Holdings Group Limited3.79%$ 3.795 millions
Guardion Health Sciences Inc 3.76%$ 3.764 millions
Zoetis Inc 3.71%$ 3.711 millions


About Cardiovascular Systems Inc Revenue Growth Rates (CSII), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cardiovascular Systems Inc (CIK 1180145).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001180145-23-000016
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cardiovascular Systems Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.